ww compounded semaglutide With B6 (Pyridoxine) Injectable Semaglutide | Compounded GLP-1

FDA-registered compounding pharmacies must follow strict pharmaceutical manufacturing requirements and test their preparations for potency (correct concentration), sterility (absence of contamination), and stability (maintaining effectiveness over storage period)

We do everything in our power to ensure that our customers are satisfied, even after our products are delivered

Always look after your health by talking to trusted medical experts

Semaglutide (Wegovy) FDA-approved for: Chronic weight management Treatment of Metabolic dysfunction-Associated Steatohepatitis (MASH) approved August 2025 FDA-indicated for: Reducing risk of heart attack, stroke, and cardiovascular death in adults with established cardiovascular disease who are obese or overweight Weekly injection Clinical trials show an average weight loss of 1215% of body weight

Sharp printing, accurate color, and consistent quality are required for all custom packaging